Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


For optimal antibody effectiveness, sometimes less is more

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Nature 614, 416-418 (2023)



  1. Yu, X. et al. Nature 614, 539–547 (2023).

    Article  Google Scholar 

  2. Mayes, P. A., Hance, K. W. & Hoos, A. Nature Rev. Drug Discov. 17, 509–527 (2018).

    Article  PubMed  Google Scholar 

  3. Valitutti, S. Front. Immunol. 3, 272 (2012).

    Article  PubMed  Google Scholar 

  4. Zhu, D.-M., Dustin, M. L., Cairo, C. W. & Golan, D. E. Biophys. J. 92, 1022–1034 (2007).

    Article  PubMed  Google Scholar 

  5. Nandi, S. K., Österle, D., Heidenreich, M., Levy, E. D. & Safran, S. A. Phys. Rev. Lett. 129, 128102 (2022).

    Article  PubMed  Google Scholar 

  6. Faroudi, M. et al. Proc. Natl Acad. Sci. USA 100, 14145–14150 (2003).

    Article  PubMed  Google Scholar 

  7. Malik-Chaudhry, H. K. et al. mAbs 13, 1890411 (2021).

    Article  PubMed  Google Scholar 

  8. Wei, J. et al. Sci. Transl. Med. 14, eabn1082 (2022).

    Article  PubMed  Google Scholar 

Download references

Competing Interests

S.J.D. is an employee of and shareholder in AstraZeneca.


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links